Back
Product details:
CAS
459789-99-2
Purity
95%
Obeticholic acid is a bile acid analog and farnesoid X receptor agonist used to treat primary biliary cholangitis in adult patients with inadequate clinical response or intolerance to UDCA.
Properties
Name
Obeticholic acid
Smiles
CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(=O)O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14
Targets
Please log in to see this information
SDS
(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxycholan-24-oic acid | 3α, 7α-dihydroxy-6α-ethyl-5β-cholan-24-oic acid | 6(α)-ethyl-chenodeoxycholic acid | 6-ECDCA | 6-alpha-ethyl chenodeoxycholic acid | 6-ethyl-CDCA | 6-ethylchenodeoxycholic acid | INT-747 | OCA | obeticholic acid | ocaliva
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$75
2 mg
$79
5 mg
$84
10 mg
$110
15 mg
$136
20 mg
$162
25 mg
$176
30 mg
$194
35 mg
$212
40 mg
$231
45 mg
$246
50 mg
$268
75 mg
$404
100 mg
$470
Quantity
1
Total amount
$ 84
(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxycholan-24-oic acid | 3α, 7α-dihydroxy-6α-ethyl-5β-cholan-24-oic acid | 6(α)-ethyl-chenodeoxycholic acid | 6-ECDCA | 6-alpha-ethyl chenodeoxycholic acid | 6-ethyl-CDCA | 6-ethylchenodeoxycholic acid | INT-747 | OCA | obeticholic acid | ocaliva
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.